Cabaletta Bio, Inc. (CABA) › Shareholders' EquityCabaletta Bio, Inc. (CABA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$249.0K2018: -$10.69M2019: $138.32M2020: $109.54M2021: $117.96M2022: $104.52M2023: $236.20M2024: $152.34M2025: $112.05M$112.05M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$112.05M-26.4%2024$152.34M-35.5%2023$236.20M+126.0%2022$104.52M-11.4%2021$117.96M+7.7%2020$109.54M-20.8%2019$138.32M+1393.9%2018-$10.69M-4193.2%2017-$249.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share